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Background
Patients with severe asthma are less responsive to the
beneficial effects of corticosteroid (CS) therapy. CS med-
iate their therapeutic effects through activation of the
glucocorticoid receptor (GR) and suppression of NF-B
activity.
Objectives
We investigated whether i) corticosteroid insensitivity was
present in airway smooth muscle cells (ASMC) of patients
with severe asthma and ii) there was a defect in the mole-
cular action of the glucocorticoid receptor (GR) in ASMC
of patients with severe asthma.
Methods
ASMC of the healthy (12), non-severe (NSA; 10) and
severe asthma (SA; 10) obtained from endobronchial
biopsies were pretreated with dexamethasone (Dex) at
10-10-10-6 M followed by stimulation with TNF-a and
IFN-g (10 ng/ml each), alone or in combination (T+I).
CXCL8 and CCL11 release was determined by ELISA,
GR and p65 protein was assessed by Western Blot,
mRNA by RT-qPCR and p65 recruitment to the CCL11
promoter by ChIP assay.
Results
CCL11 release was higher in ASMC of non-severe but
not severe asthmatics and non-asthmatic controls;
CXCL8 release was similar in all groups. In severe asth-
matics dex (10-6 M) caused less suppression of CCL11
(42% vs 14%, p<0.05) and CXCL8 (47.88% vs 26.7%,
p<0.05) compared to non-severe asthmatics or healthy
controls, respectively. TNFa-induced phospho-p38 mito-
gen-activated protein kinase was increased in severe asth-
matic ASMC compared to non-severe and non-asthmatics
while a p38 inhibitor increased the inhibitory effect of dex.
GR expressed in severe and non-severe asthma was 49% of
that in the healthy (p<0.01). Dexamethasone-induced GR
nuclear translocation at 2h, in SA, was 60% of that in
either the healthy or NSA (p<0.05). TNF-a induced
greater p65 mRNA expression in SA whereas baseline and
TNFa-induced nuclear abundance, and dexamethasone
suppression of p65 expression, were similar between
groups. While not modulating p65 nuclear translocation,
dex attenuated p65 recruitment to the CCL11 promoter in
the healthy and NSA, but this suppressive effect was
impaired in SA.
Conclusions
Airway smooth muscle cells of patients with severe
asthma are corticosteroid insensitive; this may be second-
ary to heightened p38 mitogen-activated protein kinase.
Decreased GR expression with impaired nuclear translo-
cation in ASMC, associated with reduced dexametha-
sone-mediated attenuation of p65 recruitment to gene
promoters, may underlie the mechanism of CS insensitiv-
ity in severe asthma.
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